Skip to main content
Download PDF
- Main
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.
- Salvadori, Nicolas;
- Fan, Bo;
- Teeyasoontranon, Waralee;
- Ngo-Giang-Huong, Nicole;
- Phanomcheong, Siriluk;
- Luvira, Anita;
- Puangsombat, Achara;
- Suwannarat, Arunrat;
- Srirompotong, Ussanee;
- Putiyanun, Chaiwat;
- Cressey, Tim;
- Decker, Luc;
- Khamduang, Woottichai;
- Harrison, Linda;
- Tierney, Camlin;
- Shepherd, John;
- Kourtis, Athena;
- Bulterys, Marc;
- Siberry, George;
- Jourdain, Gonzague
- et al.
Published Web Location
https://doi.org/10.1093/cid/ciy982Abstract
In a randomized, double-blind, placebo-controlled trial of tenofovir disoproxil fumarate (TDF) use from 28 weeks gestational age to 2 months postpartum to prevent mother-to-child transmission of hepatitis B virus, there was no significant effect of maternal TDF use on maternal or infant bone mineral density 1 year after delivery/birth. Clinical Trials Registration. NCT01745822.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%